High throughput genomic and proteomic technologies in the fight against infectious diseases

Journal of Infection in Developing Countries

Volumn 7, Issue 3, 2013, Pages 182-190

  Tanca, Alessandro ^a,b   Deligios, Massimo ^a,b   Addis, Maria Filippa ^b   Uzzau, Sergio ^a,b  

^a UNIVERSITY OF SASSARI   (Italy)

^b Porto Conte Ricerche Srl   (Italy)

Author keywords

Biomarkers; Genomics; Proteogenomics; Proteomics; Reverse vaccinology

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN; RNA 16S;

GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOGENICITY; INFECTION; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DIAGNOSIS; NONHUMAN; POINT OF CARE TESTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL ELECTROPHORESIS;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; GENOMICS; HUMANS; PROTEOMICS;

EID: 84875150197     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3027     Document Type: Review

References (71)

1. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, McKenney K, Sutton S, FitzHugh W, Fields C, Gocayne JD, Scott J, Shirley R, Liu L-I, Glodek A, Kelley JM, Weidman JF, Phillips CA, Spriggs T, Hedblom E, Cotton MD, Teresa R. Utterback TR, Hanna MC, Nguyen DT, Saudek DM, Brandon RC, Fine LD, Fritchman JL, Fuhrmann JL, Geoghagen NSM, Gnehm CL, McDonald LA, Small KV, Fraser CM, Smith HO, Craig Venter JC (1995) An approach for genome analysis based on sequencing and assembly Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269: 496-512.
2. Loman NJ, Constantinidou C, Chan JZ, Halachev M, Sergeant M, Penn CW, Robinson ER, Pallen MJ (2012) High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol 10: 599-606.
3. Nagarajan N, Cook C, Di Bonaventura M, Ge H, Richards A, Bishop-Lilly KA, DeSalle R, Read TD, Pop M (2010) Finishing genomes with limited resources: lessons from an ensemble of microbial genomes. BMC Genomics 11: 242.
4. Richardson EJ and Watson M (2012) The automatic annotation of bacterial genomes. Brief Bioinform.
5. Lottspeich F (2009) Introduction to proteomics. Methods Mol Biol 564: 3-10.
6. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL, Humphery-Smith I (1995) Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16: 1090-1094.
7. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, Williams KL (1996) Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 13: 19-50.
8. Ahrens CH, Brunner E, Qeli E, Basler K, Aebersold R (2010) Generating and navigating proteome maps using mass spectrometry. Nat Rev Mol Cell Biol 11: 789-801.
9. Westermeier R, Naven T, Höpker HR (2008) Proteomics in Practice: A Guide to Successful Experimental Design: Westheim: Wiley-VCH 482p.
10. MacBeath G (2002) Protein microarrays and proteomics. Nat Genet 32 Suppl: 526-532.
11. Klose J (1975) Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26: 231-243.
12. O'Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021.
13. Görg A, Weiss W, Dunn MJ (2004) Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685.
14. Unlu M, Morgan ME, Minden JS (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18: 2071-2077.
15. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44.
16. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR 3rd (1999) Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17: 676-682.
17. Washburn MP, Wolters D, Yates JR, 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19: 242-247.
18. Lambert JP, Ethier M, Smith JC, Figeys D (2005) Proteomics: from gel based to gel free. Anal Chem 77: 3771-3787.
19. Schirle M, Heurtier MA, Kuster B (2003) Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 2: 1297-1305.
20. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999.
21. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
22. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
23. Stemmann O, Zou H, Gerber SA, Gygi SP, Kirschner MW (2001) Dual inhibition of sister chromatid separation at metaphase. Cell 107: 715-726.
24. Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC, Haynes PA (2011) Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 11: 535-553.
25. LaBaer J and Ramachandran N (2005) Protein microarrays as tools for functional proteomics. Curr Opin Chem Biol 9: 14-19.
26. Gallien S, Duriez E, Domon B (2011) Selected reaction monitoring applied to proteomics. J Mass Spectrom 46: 298-312.
27. Frishman D (2007) Protein annotation at genomic scale: the current status. Chem Rev 107: 3448-3466.
28. Liolios K, Chen IM, Mavromatis K, Tavernarakis N, Hugenholtz P, Markowitz VM, Kyrpides NC (2010) The Genomes On Line Database (GOLD) in 2009: status of genomic and metagenomic projects and their associated metadata. Nucleic Acids Res 38: D346-354.
29. Brenner SE (1999) Errors in genome annotation. Trends Genet 15: 132-133.
30. de Souza GA, Malen H, Softeland T, Saelensminde G, Prasad S, Jonassen I, Wiker HG (2008) High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics 9: 316.
31. Ansong C, Purvine SO, Adkins JN, Lipton MS, Smith RD (2008) Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief Funct Genomic Proteomic 7: 50-62.
32. Armengaud J (2009) A perfect genome annotation is within reach with the proteomics and genomics alliance. Current Opinion in Microbiology 12: 292-300.
33. Jaffe JD, Berg HC, Church GM (2004) Proteogenomic mapping as a complementary method to perform genome annotation. Proteomics 4: 59-77.
34. Yates JR, 3rd, Eng JK, McCormack AL (1995) Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases. Anal Chem 67: 3202-3210.
35. Mann M and Pandey A (2001) Use of mass spectrometry-derived data to annotate nucleotide and protein sequence databases. Trends Biochem Sci 26: 54-61.
36. Renuse S, Chaerkady R, Pandey A (2011) Proteogenomics. Proteomics 11: 620-630.
37. Gupta N, Tanner S, Jaitly N, Adkins JN, Lipton M, Edwards R, Romine M, Osterman A, Bafna V, Smith RD, Pevzner PA (2007) Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res 17: 1362-1377.
38. Lasonder E, Ishihama Y, Andersen JS, Vermunt AM, Pain A, Sauerwein RW, Eling WM, Hall N, Waters AP, Stunnenberg HG, Mann M (2002) Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419: 537-542.
39. Xia D, Sanderson SJ, Jones AR, Prieto JH, Yates JR, Bromley E, Tomley FM, Lal K, Sinden RE, Brunk BP, Roos DS, Wastling JM (2008) The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation. Genome Biol 9: R116.
40. Pawar H, Sahasrabuddhe NA, Renuse S, Keerthikumar S, Sharma J, Kumar GS, Venugopal A, Sekhar NR, Kelkar DS, Nemade H, Khobragade SN, Muthusamy B, Kandasamy K, Harsha HC, Chaerkady R, Patole MS, Pandey A (2012) A proteogenomic approach to map the proteome of an unsequenced pathogen-Leishmania donovani. Proteomics 12: 832-844.
41. Prasad TS, Harsha HC, Keerthikumar S, Sekhar NR, Selvan LD, Kumar P, Pinto SM, Muthusamy B, Subbannayya Y, Renuse S, Chaerkady R, Mathur PP, Ravikumar R, Pandey A (2012) Proteogenomic analysis of Candida glabrata using high resolution mass spectrometry. J Proteome Res 11: 247-260.
42. Zhao L, Liu L, Leng W, Wei C, Jin Q (2011) A proteogenomic analysis of Shigella flexneri using 2D LC-MALDI TOF/TOF. BMC Genomics 12: 528.
43. Payne SH, Huang ST, Pieper R (2010) A proteogenomic update to Yersinia: enhancing genome annotation. BMC Genomics 11: 460.
44. Schrimpe-Rutledge AC, Jones MB, Chauhan S, Purvine SO, Sanford JA, Monroe ME, Brewer HM, Payne SH, Ansong C, Frank BC, Smith RD, Peterson SN, Motin VL, Adkins JN (2012) Comparative omics-driven genome annotation refinement: application across Yersiniae. PLoS ONE 7: e33903.
45. Nichols JH (2007) Point of care testing. Clin Lab Med 27: 893-908, viii.
46. Trevino EA and Weissfeld AS (2007) The case for point-of-care testing in infectious-disease diagnosis. Clinical Microbiology Newsletter 29: 177-179.
47. Overturf GD (2008) CLIA waived testing in infectious diseases. Pediatr Infect Dis J 27: 1009-1012.
48. Bissonnette L and Bergeron MG (2010) Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin Microbiol Infect 16: 1044-1053.
49. Weile J and Knabbe C (2009) Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal Bioanal Chem 394: 731-742.
50. Nougairede A, Ninove L, Zandotti C, De Lamballerie X, Gazin C, Drancourt M, La Scola B, Raoult D, Charrel RN (2009) Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus. PLoS One 5:e9215.
51. Peeling RW and Mabey D (2010) Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 16: 1062-1069.
52. Nargessi D and Ou CY (2010) MagaZorb: a simple tool for rapid isolation of viral nucleic acids. J Infect Dis 201 Suppl 1: S37-41.
53. Piepenburg O, Williams CH, Stemple DL, Armes NA (2006) DNA detection using recombination proteins. PLoS Biol 4: e204.
54. Zelada-Guillen GA, Riu J, Duzgun A, Rius FX (2009) Immediate detection of living bacteria at ultralow concentrations using a carbon nanotube based potentiometric aptasensor. Angew Chem Int Ed Engl 48: 7334-7337.
55. Rodriguez WR, Christodoulides N, Floriano PN, Graham S, Mohanty S, Dixon M, Hsiang M, Peter T, Zavahir S, Thior I, Romanovicz D, Bernard B, Goodey AP, Walker BD, McDevitt JT (2005) A microchip CD4 counting method for HIV monitoring in resource-poor settings. PLoS Med 2: e182.
56. Sia SK, Linder V, Parviz BA, Siegel A, Whitesides GM (2004) An integrated approach to a portable and low-cost immunoassay for resource-poor settings. Angew Chem Int Ed Engl 43: 498-502.
57. Sorger PK (2008) Microfluidics closes in on point-of-care assays. Nat Biotechnol 26: 1345-1346.
58. Obeid PJ and Christopoulos TK (2003) Continuous-flow DNA and RNA amplification chip combined with laser-induced fluorescence detection. Analytica Chimica Acta 494: 1-9.
59. Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3: 445-450.
60. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, Henriques-Normark B, Ortqvist A, Kalin M, von Gabain A, Nagy E (2008) Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 205: 117-131.
61. Rodriguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, Mora M, Scarselli M, Doro F, Ferrari G, Garaguso I, Maggi T, Neumann A, Covre A, Telford JL, Grandi G (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24: 191-197.
62. Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 103: 10834-10839.
63. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G (2005) Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309: 148-150.
64. Mora M, Bensi G, Capo S, Falugi F, Zingaretti C, Manetti AG, Maggi T, Taddei AR, Grandi G, Telford JL (2005) Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc Natl Acad Sci U S A 102: 15641-15646.
65. Gianfaldoni C, Censini S, Hilleringmann M, Moschioni M, Facciotti C, Pansegrau W, Masignani V, Covacci A, Rappuoli R, Barocchi MA, Ruggiero P (2007) Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. Infect Immun 75: 1059-1062.
66. Moriel DG, Bertoldi I, Spagnuolo A, Marchi S, Rosini R, Nesta B, Pastorello I, Corea VA, Torricelli G, Cartocci E, Savino S, Scarselli M, Dobrindt U, Hacker J, Tettelin H, Tallon LJ, Sullivan S, Wieler LH, Ewers C, Pickard D, Dougan G, Fontana MR, Rappuoli R, Pizza M, Serino L (2010) Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci U S A 107: 9072-9077.
67. Mehta P, Cook D (2010) The Diagnostic Innovation Map: Medical Diagnostics for the Unmet Needs of the Developing World-Report. BIO Ventures for Global Health. Available: www.bvgh.org/LinkClick.aspx?fileticket=-a1C6u2LE4w%3d&tabid=91
68. Gift TL, Pate MS, Hook EW, 3rd, Kassler WJ (1999) The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis 26: 232-240.
69. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, Methé BA, Huttenhower C (2012) The human microbiome project: a community resource for the healthy human microbiome. PLoS Biol 10: e1001377.
70. Human Microbiome Project Consortium (2012) A framework for human microbiome research. Nature 486: 215-221.
71. Davenport CF and Tummler B (2013) Advances in computational analysis of metagenome sequences. Environ Microbiol 15:1-5.